<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">G3: Genes, Genomes, Genetics</journal-id>
<journal-id journal-id-type="pmc">G3: Genes, Genomes, Genetics</journal-id>
<journal-id journal-id-type="publisher-id">G3: Genes, Genomes, Genetics</journal-id>
<journal-title>G3: Genes, Genomes, Genetics</journal-title>
<abbrev-journal-title abbrev-type="full">G3</abbrev-journal-title>
<issn pub-type="epub">2160-1836</issn>
<publisher><publisher-name>Genetics Society of America</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">GGG_040824</article-id>
<article-id pub-id-type="doi">10.1534/g3.117.040824</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Investigation</subject></subj-group>
</article-categories>
<title-group>
<article-title>Reliable CRISPR/Cas9 Genome Engineering in <italic>Caenorhabditis elegans</italic> Using a Single Efficient sgRNA and an Easily Recognizable Phenotype</article-title>
<?RFL  S. El Mouridi <italic>et al.</italic>?>
<?RFR  <italic>d10</italic>-Based Genome Engineering?>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>El Mouridi</surname><given-names>Sonia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lecroisey</surname><given-names>Claire</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tardy</surname><given-names>Philippe</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mercier</surname><given-names>Marine</given-names></name></contrib><contrib contrib-type="author"><name><surname>Leclercq-Blondel</surname><given-names>Alice</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zariohi</surname><given-names>Nora</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Boulin</surname><given-names>Thomas</given-names></name><xref ref-type="corresp" rid="cor1"><sup>1</sup></xref></contrib>
<aff id="aff1">Institut NeuroMyoG&#x00E8;ne, Universit&#x00E9; Claude Bernard Lyon 1, 69100 Villeurbanne, France</aff>
</contrib-group>
<author-notes>
<fn id="afn1"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></fn>
<corresp id="cor1"><label>1</label>Corresponding author: Institut NeuroMyoG&#x00E8;ne, Universit&#x00E9; Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, 8 Rue Raphael Dubois, 69100 Villeurbanne, France. E-mail: <email>thomas.boulin@univ-lyon1.fr</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>05</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>7</day><month>3</month><year>2017</year></pub-date>
<volume>7</volume>
<issue>5</issue>
<fpage>0</fpage>
<lpage>0</lpage>
<history>
<date date-type="received"><day>03</day><month>02</month><year>2017</year></date><date date-type="accepted"><day>02</day><month>03</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017 El Mouridi <italic>et al.</italic></copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:title="pdf" xlink:href="GGG_040824.pdf"/>
<abstract>
<p>CRISPR/Cas9 genome engineering strategies allow the directed modification of the <italic>Caenorhabditis elegans</italic> genome to introduce point mutations, generate knock-out mutants, and insert coding sequences fo<!-- Q1 -->r epitope or fluorescent tags<!-- DBComment1 -->. Three practical aspects, however, complicate such experiments. First, the efficiency and specificity of single-guide RNAs (sgRNA) cannot be reliably predicted. Second, the detection of animals carrying genome edits can be challenging in the absence of clearly visible or selectable phenotypes. Third, the sgRNA target site must be inactivated after editing to avoid further double-strand break events. We describe here a strategy that addresses these complications by transplanting the protospacer of a highly efficient sgRNA into a gene of interest to render it amenable to genome engineering. This sgRNA targeting the <italic>dpy-10</italic> gene generates genome edits at comparatively high frequency. We demonstrate that the transplanted protospacer is cleaved at the same time as the <italic>dpy-10</italic> gene. Our strategy generates scarless genome edits because it no longer requires the introduction of mutations in endogenous sgRNA target sites. Modified progeny can be easily identified in the F1 generation, which drastically reduces the number of animals to be tested by PCR or phenotypic analysis. Using this strategy, we reliably generated precise deletion mutants, transcriptional reporters, and translational fusions with epitope tags and fluorescent reporter genes. In particular, we report here the first use of the new red fluorescent protein mScarlet in a multicellular organism. wrmScarlet, a <italic>C. elegans</italic>-optimized version, dramatically surpassed TagRFP-T by showing an eightfold increase in fluorescence in a direct comparison.<!-- Q2 --><!-- Q3 --><!-- Q4 --><!-- Q5 --><!-- Q6 --><!-- Q7 --></p>
</abstract>
<kwd-group>
<kwd>CRISPR/Cas9 genome engineering</kwd><kwd><italic>Caenorhabditis elegans</italic></kwd><kwd>mScarlet</kwd><kwd><italic>dpy-10</italic></kwd><kwd>coconversion</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="40"/>
<page-count count="0"/></counts>
<!--Institut NeuroMyoG&#x00E8;ne, Universit&#x00E9; Claude Bernard Lyon 1, 69100 Villeurbanne, France-->
</article-meta>
</front>
<body>
<p>The pace of technical developments allowing the direct manipulation of genome sequences has seen a marked acceleration in recent years with the emergence of RNA-targeted nucleases derived from bacterial immune systems (<xref ref-type="bibr" rid="bib12">Doudna and Charpentier 2014</xref>; <xref ref-type="bibr" rid="bib39">Zetsche <italic>et al.</italic> 2015</xref>)<!-- DBComment2 --> <!-- DBComment3 --> <!-- DBComment4 --> <!-- DBComment5 --> <!-- DBComment6 --> <!-- DBComment7 -->. In particular, the binary system relying on the <italic>Streptococcus pyogenes</italic> Cas9 endonuclease <!-- Q8 -->targeted by CRISPR (clustered, regularly interspaced, short, palindromic repeat) RNAs has been successfully used to generate point mutations, deletion, or DNA insertions in an ever-growing number of experimental systems<!-- DBComment8 -->. <italic>S. pyogenes</italic> CRISPR/Cas9 has been adapted early on in the model nematode <italic>Caenorhabditis elegans</italic> (<xref ref-type="bibr" rid="bib14">Friedland <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib8">Dickinson <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib5">Chen <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib15">Fr&#x00F8;kj&#x00E6;r-Jensen 2013</xref>; <xref ref-type="bibr" rid="bib7">Dickinson and Goldstein 2016</xref>). Previously, heritable genome engineering could only be achieved in <italic>C. elegans</italic> by remobilizing a <italic>Drosophila</italic> <italic>Mos1</italic> transposon, which could be inserted and excised in the germline (<xref ref-type="bibr" rid="bib33">Robert and Bessereau 2007</xref>; <xref ref-type="bibr" rid="bib16">Fr&#x00F8;kj&#x00E6;r-Jensen <italic>et al.</italic> 2010</xref>).</p>
<p>Despite great promise and early success, day-to-day CRISPR experiments are often not straightforward. Different factors might explain variability and inefficiency of CRISPR/Cas9 genome engineering in <italic>C. elegans</italic>. One specific reason could be the limited expression of heterologous genes in the germline due to dedicated cosuppression mechanisms (<xref ref-type="bibr" rid="bib25">Kelly and Fire 1998</xref>). One approach to circumvent this problem has been to inject preassembled ribonucleoprotein (RNP) complexes of SpCas9 and CRISPR RNAs (crRNA &#x2013; tracrRNA duplexes) directly into the germline (<xref ref-type="bibr" rid="bib6">Cho <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib31">Paix <italic>et al.</italic> 2015</xref>).</p>
<p>Another general reason for CRISPR failure is that efficacy and specificity vary greatly between different single-guide RNAs (sgRNA). Systematic analyses in different systems have led to the prediction that protospacers terminating by a single guanosine (GNGG) or ideally a double guanosine motif (GGNGG) are generally more effective (<xref ref-type="bibr" rid="bib10">Doench <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib13">Farboud and Meyer 2015</xref>). To estimate the prevalence of such sites, we selected a set of 22 genes coding for two-pore domain potassium channel subunits and collected the sequences of all sgRNA target sites in and close to exons of these genes. On average, these 22 loci contained 138 &#x00B1; 40 protospacers. We found that 20 &#x00B1; 5% of these matched the GNGG motif, and only 5 &#x00B1; 2% matched the GGNGG motif (Supplemental Material, Table S1 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). Since, the proximity of an sgRNA to the target site has a positive impact on the likelihood to generate gene edits (<xref ref-type="bibr" rid="bib30">Paix <italic>et al.</italic> 2014</xref>), it is therefore likely that few or no high-efficiency sgRNAs will be situated close to a given target region.</p>
<p>One approach to compensate for low CRISPR/Cas9 activity has been to use selection strategies to increase the number of tested progeny. Antibiotic and phenotypic selection protocols have been adapted in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib38">Ward 2015</xref>; <xref ref-type="bibr" rid="bib9">Dickinson <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib29">Norris <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib7">Dickinson and Goldstein 2016</xref>; <xref ref-type="bibr" rid="bib34">Schwartz and Jorgensen 2016</xref>). They have the further advantage of reducing hands-on time and facilitate the detection of successful genome editing events. When phenotypic or antibiotic selection is not applicable, Co-CRISPR strategies can be used to increase the likelihood of identifying individuals with genome edits. These coconversion approaches consist of injecting the sgRNA targeting a locus of interest together with a second sgRNA that targets a &#x201C;marker gene&#x201D; (<xref ref-type="bibr" rid="bib26">Kim <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib1">Arribere <italic>et al.</italic> 2014</xref>). Progeny that carry a modification in the &#x201C;marker&#x201D; locus are then more likely to carry edits in the locus of interest. However, since two distinct sgRNAs do not necessarily cut with the same efficiency or in the same germ cell, effectiveness of traditional Co-CRISPR coconversion is variable and mostly indicates a successful injection and expression of Cas9 and sgRNA.</p>
<p>In addition, all available strategies require the protospacer sequence to be disrupted once the edit is generated to prevent further CRISPR/Cas9 cutting/activity. This almost always requires the introduction of point mutations in the protospacer adjacent motif (PAM) or in multiple bases of the protospacer. The consequences of such mutations in introns and up- or downstream regulatory regions are difficult, if not impossible, to predict. Similarly, silent mutations in exons can have unfavorable effects due to codon usage bias. Therefore, it would be ideal if genome edits, in particular insertions or point mutations, could be generated without modification of the surrounding original genomic sequence.</p>
<p>Finally, since CRISPR/Cas9 guide RNAs are short 19- to 20-bp-long sequences, there are often multiple closely matching sites (<italic>i.e.</italic>, differing only by a few base pairs) in the genome that could be targeted, albeit at lower frequency. While algorithms have been developed to easily predict such potential off-target sites (<xref ref-type="bibr" rid="bib22">Hsu <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib11">Doench <italic>et al.</italic> 2016</xref>), the prevalence of undesired CRISPR events has not been systematically analyzed in <italic>C. elegans</italic> and would require <italic>ad hoc</italic> experiments for each sgRNA.</p>
<p>We describe here a two-step strategy for reliable and scarless modification of the <italic>C. elegans</italic> genome using a single-guide RNA that facilitates the detection of genome engineering events based on an easily recognizable phenotype. Indeed, we reasoned that it should be possible to circumvent many practical hurdles described above if we transplanted the protospacer for a highly efficient sgRNA into a genomic locus of interest to create an &#x201C;entry strain&#x201D; that would be more amenable to genome engineering. Specifically, we inserted a protospacer and PAM from the <italic>dpy-10</italic> gene (<xref ref-type="bibr" rid="bib1">Arribere <italic>et al.</italic> 2014</xref>) &#x2013; further referred to as the &#x201C;<italic>d10</italic> site&#x201D; or &#x201C;<italic>d10</italic> sequence&#x201D; &#x2013; close to the targeted genomic region. In this &#x201C;<italic>d10</italic>-entry strain,&#x201D; we could then induce double-strand breaks at both the transplanted <italic>d10</italic> site and the endogenous <italic>dpy-10</italic> locus using a single sgRNA. We demonstrated that the <italic>d10</italic> site and the <italic>dpy-10</italic> locus were efficiently cut within the same nucleus. Finally, we found that coconversion events (insertions of fluorescent reporter genes and epitope tags) occurred on average in 8% (<italic>i.e.</italic>, 1 in 12 animals) of F1 progeny that also carried mutations in the marker gene <italic>dpy-10</italic>, revealing a high incidence of coconversion events. Since this coconversion step no longer relied on an endogenous protospacer from the targeted locus, we did not need to introduce mutations in PAM or protospacer sequences and could generate perfectly accurate and scarless genome edits. Although our strategy is especially suited to insert sequences into the genome, we could also obtain large, precisely targeted gene deletions.</p>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2">
<title>Strains generated in this study</title>
<p>N2 Bristol was used as a wild-type starting strain for transgenic lines generated in this study. Worms were raised at 20&#x00B0; on nematode growth medium and fed <italic>Escherichia coli OP50</italic>. Worms were grown at 25&#x00B0; after injection. Table S2 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link> provides a comprehensive list of the strains constructed for this study.</p>
</sec>
<sec id="s3">
<title>Molecular biology</title>
<p>Single-guide RNA expression vectors (see Supplementary Methods in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>) and plasmid repair templates were constructed using standard molecular biology techniques and Gibson assembly (<xref ref-type="bibr" rid="bib19">Gibson 2011</xref>). They were systematically validated by Sanger sequencing before injection. Tables S3 and S4 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>, respectively, list the oligonucleotides and vectors used in this study. The Cas9-expression vector pDD162 was obtained from Addgene (<xref ref-type="bibr" rid="bib8">Dickinson <italic>et al.</italic> 2013</xref>). Vectors generated for this study are available upon request.</p>
</sec>
<sec id="s4">
<title>DNA preparation and microinjection</title>
<p>The pDD162, pMD8, and pPT53 plasmids were purified using the Qiagen EndoFree Plasmid Mega Kit (Qiagen). All other vectors were prepared using Invitrogen PureLink HQ Mini Plasmid Purification Kit (ThermoFisher Scientific). Single-strand DNA repair templates were synthetized and PAGE-purified by Integrated DNA Technologies (IDT). These single-strand DNA oligonucleotides were aliquoted and stored at &#x2212;80&#x00B0; upon resuspension in IDTE (10 mM Tris, pH = 7.5, 0.1 mM EDTA, IDT). Except specified otherwise, plasmid vectors and ssDNA were diluted in water and injected at a final concentration of 50 ng/&#x00B5;l; co-injection markers were injected at 5 ng/&#x00B5;l. DNA mixes were injected into a single gonad of 1-d-old adult hermaphrodites raised at 20&#x00B0;. They were then cloned onto individual plates after overnight incubation at 25&#x00B0;.</p>
</sec>
<sec id="s5">
<title>PCR screening</title>
<p>PCR DNA amplification was performed on crude worm extracts. In brief, worms were collected in ice-cold 1&#x00D7; M9 buffer, and 5 &#x03BC;l of packed worms were lysed by freeze thaw lysis in 14 &#x03BC;l of Worm Lysis Buffer [50 mM KCl, 10 mM Tris-HCl (pH = 8.3), 2.5 mM MgCl<sub>2</sub>, 0.45% Nonidet P-40, 0.45% Tween 20, 0.01% (w/v) Gelatin], to which 1 &#x03BC;l of proteinase K was added (1 mg/ml final concentration). After freezing at &#x2212;80&#x00B0;, lysates were incubated for 1 hr at 65&#x00B0;, and proteinase K was inactivated by further incubation at 95&#x00B0; for 20 min.</p>
<p>High-fidelity DNA polymerases (Q5 High-Fidelity DNA Polymerase, New England Biolabs; Phusion High-Fidelity PCR Kit, Thermo Fisher Scientific) were used for PCR amplification to maximize the chances of recovery of desired modifications. Indeed, when we generated the <italic>TagRFP-T</italic>::<italic>twk-18</italic> knock-in strain, we initially screened 77 F1 clones using a low-fidelity DNA Polymerase (Taq&#x2019;Ozyme, Ozyme) and found no edits. When we immediately rescreened the same worm lysates with a more processive, high-fidelity DNA polymerase (Phusion, ThermoFisher Scientific) we identified five positive clones. PCR primers used for this study are listed in Table S3 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>.</p>
</sec>
<sec id="s6">
<title>Generation of sgRNA expression vector by single-strand DNA isothermal ligation</title>
<p>All sgRNA expression vectors were built using the novel pPT2 vector (see below<!-- Q9 --> and Supplementary Methods in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>)<!-- DBComment9 -->. In brief, pPT2 was linearized by PmeI/SexAI double digestion. The protospacer sequence was then inserted by isothermal ligation using a single-strand oligonucleotide containing the protospacer sequence flanked by 20-bp-long homology arms corresponding to the sequences upstream of PmeI and downstream of SexAI. If it was not already present in the sequence, a guanine residue was manually added 5&#x2032; to the protospacer sequence to optimize U6 promoter activity. A unique identifier was given to each sgRNA using the following nomenclature: CRpXYn, where &#x201C;CR&#x201D; stands for &#x201C;CRISPR/Cas9 recognition site&#x201D; and pXYn is the name of the corresponding sgRNA expression plasmid.</p>
</sec>
<sec id="s7">
<title>Codon-optimization of mScarlet</title>
<p>wrmScarlet was generated by gene synthesis (Gblock, IDT) based on the mScarlet sequence (Genbank KY021423; <xref ref-type="bibr" rid="bib2">Bindels <italic>et al.</italic> 2017</xref>; Figure S3 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). Codon-optimization was performed using the &#x201C;<italic>C. elegans</italic> codon adapter&#x201D; service (<xref ref-type="bibr" rid="bib32">Redemann <italic>et al.</italic> 2011</xref>) with the following parameters: &#x201C;<italic>0 introns</italic>,&#x201D; &#x201C;<italic>optimize for weak mRNA structure at ribosome binding site</italic>,&#x201D; and &#x201C;<italic>avoid splice sites in coding region</italic>.&#x201D; The Gblock fragment library was combined by isothermal ligation with left and right homology regions flanking the <italic>d10</italic> sequence in <italic>twk-18</italic>(<italic>bln213</italic>) to generate the repair template pSEM87. The wrmScarlet cDNA sequence is available upon request.</p>
</sec>
<sec id="s8">
<title>Microscopy and fluorescence quantification</title>
<p>Freely moving worms were observed on nematode growth media (NGM) <!-- Q10 -->plates using an AZ100 macroscope (Nikon) equipped with a Flash 4.0 CMOS camera (Hamamatsu Photonics)<!-- DBComment10 -->.</p>
<p>Confocal imag<!-- Q11 -->ing was performed using an inverted confocal microscope (Olympus IX83) equipped with a confocal scanner unit spinning-disk scan head (Yogokawa) and an electron multiplying charge-coupled device camera (iXon Ultra 888)<!-- DBComment11 -->. Worms were imaged on 2% fresh agar pads mounted in M9 solution containing 50 mM NaN<sub>3</sub>.</p>
<p>Comparison of wrmScarlet and TagRFP-T fluorescence was performed as follows: (1) confocal stacks of the head region were acquired for TagRFP-T and wrmScarlet knock-in strains on the same day, using identical settings, and NaN<sub>3</sub> immobilization; (2) the same number of confocal slices was selected from each stack; (3) stacks were projected by summing fluorescence at each pixel position in the stack; (4) total fluorescence was measured in areas of identical size and position relative to the anterior tip of the worm and pharynx; and (5) total fluorescence was corrected by subtracting equipment noise, <italic>i.e.</italic>, fluorescence measured in an area of the same size outside of the sample.</p>
</sec>
<sec id="s9">
<title>Data availability</title>
<p>All <italic>C. elegans</italic> strains and plasmids described in this study are available upon request<!-- Q12 --><!-- DBComment12 -->. The authors state that all data necessary for confirming the conclusions presented in the article are represented fully within the article.</p>
</sec>
</sec>
<sec id="s10" sec-type="results">
<title>Results</title>
<sec id="s11">
<title>Generation of d10-entry strains as a starting point for robust and precise gene modification</title>
<p>Our str<!-- Q13 -->ategy starts with the insertion of the <italic>d10</italic> sequence (<italic>i.e</italic><!-- DBComment13 -->., <italic>dpy-10</italic> protospacer + PAM) into the locus of interest (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). First, we targeted three positions in two genes coding for two-pore domain potassium channel subunits: (1) the ATG start site of <italic>sup-9</italic>, (2) the ATG of the <italic>egl-23b</italic> isoform, and (3) the common stop codon of all <italic>egl-23</italic> isoforms (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Next, we predicted all possible sgRNA sequences within a 50-base window around these positions, and selected sgRNAs close to the ATG or stop codons. Using multiple sgRNAs increases the chances of finding at least one sgRNA that cuts efficiently enough to insert the <italic>d10</italic> site at the desired location. We then defined the portion of the gene to be replaced by the <italic>d10</italic> site, based on the positions of the most upstream and most downstream PAM sequences. Finally, we designed a single-strand oligonucleotide sequence (ssON) containing the <italic>d10</italic> sequence flanked by up- and downstream homology regions of &#x223C;50 bases (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). This ssON could serve as a repair template with all selected sgRNAs since it did not contain their protospacer or PAM sequences.</p>
<fig id="fig1" position="float" fig-type="figure"><label>Figure 1</label><caption><p>Generation of <italic>d10</italic>-entry strains. (A) Insertion of the <italic>d10</italic> sequence into (A<!-- DBComment16 -->a<!-- Q16 -->) <italic>egl-23b</italic>, (Ab) <italic>egl-23 C-term</italic>, (Ac) <italic>sup-9</italic>, and (Ad) <italic>twk-18</italic> using a single-strand oligonucleotide repair template compatible with multiple sgRNAs. Genes and their intron/exon structure are displayed in the 5&#x2032;&#x2013;3&#x2032; orientation. The ssON repair templates are represented by black arrows (containing the <italic>d10</italic> sequence in green) above the coding strand and translation of the target gene. Correspondence of homology regions between the ssON repair template and genomic locus is indicated in gray. sgRNA binding sites are indicated by blue open arrows. (B) <italic>unc-58</italic> coconversion is used to detect the insertion of <italic>d10</italic> sequences into a gene of interest. <italic>unc-58</italic>(<italic>e665</italic>) mutants are easily identified in the F1 progeny of injected P0 animals based on their straight body posture, lack of mobility, and characteristic rotation around the antero-posterior body axis. RT, repair template. (C) <italic>Ban</italic>I, BssSI, and BsrBI restriction sites are present in the <italic>d10</italic> protospacer sequence and are used for RFLP analysis. The Cas9 double-strand break site is indicated by an arrowhead. (D) <italic>R12E2.15</italic> contains the only predicted off-target site of the <italic>d10</italic> sgRNA. Four base changes (in pink) distinguish both sites. A BsrBI site follows the Cas9 double-strand break site (indicated by an arrowhead), between the &#x2212;3 and &#x2212;4 bases relative to the protospacer adjacent motif (PAM).</p></caption><graphic xlink:href="ggg.040824fig1"></graphic></fig>
<p>Next, we built the necessary sgRNA expression constructs using a novel vector and assembly strategy. This vector (pPT2) is composed of an RNA Polymerase III U6 promoter from <italic>K09B11.12</italic> (<xref ref-type="bibr" rid="bib14">Friedland <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib24">Katic <italic>et al.</italic> 2015</xref>) followed by two restriction sites (PmeI and SexAI), followed by the sgRNA portion corresponding to the CRISPR tracrRNA and 3&#x2032; UTR of <italic>K09B11.12</italic>. This vector was linearized by restriction digest with PmeI and SexAI, and the crRNA sequence was incorporated by isothermal ligation (Gibson assembly; <xref ref-type="bibr" rid="bib19">Gibson 2011</xref>) using a single single-strand DNA oligonucleotide (see <italic>Materials and Methods</italic> and Supplementary Methods in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). These sgRNA expression vectors were systematically validated using Sanger sequencing.</p>
<p>Since it is not possible to predict the efficiency of an sgRNA <italic>a priori</italic>, we reasoned that we could increase the likelihood of finding a <italic>d10</italic> insertion at the locus of interest by using a moderately efficient Co-CRISPR. We chose a previously described reagent combination that introduces a mutation in the two-pore domain potassium channel <italic>unc-58</italic> and replicates the L428F amino acid change found in the <italic>unc-58</italic>(<italic>e665</italic>) reference allele (<xref ref-type="bibr" rid="bib1">Arribere <italic>et al.</italic> 2014</xref>). <italic>unc-58</italic>(<italic>e665</italic>) produces a dominant and easily recognizable phenotype. Worms have a straight body posture and are essentially unable to move on solid NGM medium throughout their postembryonic development (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). However, they are viable and fertile. <italic>unc-58</italic>(<italic>e665</italic>)-like progeny can be detected 2&#x2013;3 d postinjection and individual F1 worms can be cloned right away to ensure that independent events are selected.</p>
<p>To generate <italic>d10-entry</italic> strains for <italic>sup-9</italic> and <italic>egl-23</italic>, we injected wild-type N2 worms with a mix of plasmid DNA and ssON repair templates (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). In each case, the mix was composed of (i) a Cas9 expression vector (pDD162), (ii) the sgRNA expression vector targeting <italic>unc-58</italic> (pPT53), (iii) one gene-specific sgRNA expression vector, (iv) the ssON to introduce the <italic>e665</italic> mutation AF-JA-76 (<xref ref-type="bibr" rid="bib1">Arribere <italic>et al.</italic> 2014</xref>), and (v) the ssON required to introduce the <italic>d10</italic> site (<xref ref-type="fig" rid="fig1">Figure 1A</xref> and Table S3 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). After 3&#x2013;4 d, we cloned Unc-58-marked F1 worms to single plates. We then detected the presence of the <italic>d10</italic> site in the F2 population by PCR amplification and restriction digest. The <italic>d10</italic> sequence contains sites for three restriction enzymes (<italic>Ban</italic>I, BsrBI, and BssSI) that can be used for restriction fragment length polymorphism analysis (RFLP) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). In each case, we designed a PCR primer pair that produced a fragment of 500&#x2013;600 bp, centered on the <italic>d10</italic> site. In this way, we were able to generate multiple independent <italic>d10</italic>-entry strains for each of the targeted loci (<xref ref-type="table" rid="t1">Table 1</xref> and Table S2 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). In each case, we selected homozygous clones for the <italic>d10</italic> insertion that lacked the <italic>unc-58</italic> gain-of-function mutation, and validated them by Sanger sequencing around the <italic>d10</italic> sites.</p>
<table-wrap id="t1" position="float">
<label>Table 1</label><caption><title>Insertion of <italic>d10</italic> protospacer at four genomic loci</title>
</caption>
<table frame="hsides">
<col width="33.5%"/>
<col width="35.99%"/>
<col width="30.51%"/>
<thead>
<tr>
<th valign="top" align="center" scope="col">Gene (WormBase ID)</th>
<th valign="top" align="center" scope="col">Proportion of Unc-58-Marked Progeny with <italic>d10</italic> Site</th>
<th valign="top" align="center" scope="col">Proportion of Wild-Type Siblings with <italic>d10</italic> Site (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row"><italic>sup-9 II</italic> (WBGene00006318)</td>
<td valign="top" align="center">14/39 (35%)</td>
<td valign="top" align="center">3/14 (21)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row"><italic>egl-23b IV</italic> (WBGene00001190)</td>
<td valign="top" align="center">9/13 (69%)</td>
<td valign="top" align="center">6/108 (6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row"><italic>egl-23 IV</italic> (WBGene00001190)</td>
<td valign="top" align="center">8/8 (100%)</td>
<td valign="top" align="left"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row"><italic>twk-14 V</italic> (WBGene00006669)</td>
<td valign="top" align="center">0/13</td>
<td valign="top" align="left"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row"><italic>twk-18 X</italic> (WBGene00006672</td>
<td valign="top" align="center">0/1</td>
<td valign="top" align="center">7/93 (7)</td>
</tr>
</tbody></table></table-wrap>
<p>Next, we targeted the two-pore domain potassium channel subunits <italic>twk-14</italic> and <italic>twk-18</italic>. We obtained 13 Unc-58-marked progeny in the <italic>twk-14</italic> experiment, none of which contained the <italic>d10</italic> sequence, and did not pursue this experiment further. In the <italic>twk-18</italic> experiment (<xref ref-type="fig" rid="fig1">Figure 1A</xref>d), only one of 41 injected P0 worms gave a single Unc-58 worm (<xref ref-type="table" rid="t1">Table 1</xref>). Since this marked F1 worm did not incorporate the <italic>d10</italic> site in <italic>twk-18</italic>, we decided to screen its unmarked siblings. Doing so, we found seven independent insertion events out of 93 tested clones. Similarly, we found three additional <italic>d10</italic> insertion events in 14 unmarked siblings of the <italic>sup-9</italic> experiment, and six additional <italic>d10</italic> insertions in 108 unmarked siblings of the experiment targeting the ATG of the <italic>egl-23b</italic> splice variant (<xref ref-type="table" rid="t1">Table 1</xref>).</p>
<p>In conclusion, screening for Unc-58-marked F1 progeny allowed us to rapidly identify P0 individuals for which the injection was successful and CRISPR/Cas9 activity was present in the germline. Cloning Unc-58 worms at the F1 generation ensured that we selected independent edits and decreased the number of animals to clone and analyze by PCR. In three cases, we also found <italic>d10</italic> protospacer insertions in nonmarked siblings, although at lower frequencies than in Unc-58-marked F1 progeny. In total, we successfully targeted five different sites in the genome using this protocol (Table S2 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>).</p>
</sec>
<sec id="s12">
<title>Efficient and specific cutting of transplanted d10 sites</title>
<p>Different laboratories have independently reported that the sgRNA targeting the <italic>d10</italic> site is among the most efficient ones currently known (I. Katic, M. Boxem, C. Gally, J.-L. Bessereau, personal communication). The reasons for this high efficacy are unclear. For example, the site matches the GNGG motif and not GGNGG (<xref ref-type="bibr" rid="bib13">Farboud and Meyer 2015</xref>). A more favorable chromatin organization or the sequence of the <italic>dpy-10</italic> locus itself might explain high CRISPR activity in this gene. Since we transplanted only the protospacer and PAM sequences of the <italic>d10</italic> site, we decided to estimate the frequency of cuts in transplanted <italic>d10</italic> sites before attempting to engineer these loci by homologous recombination.</p>
<p>DNA double-strand breaks can be repaired by homologous recombination using the sister chromatid to restore a wild-type sequence or by nonhomologous end joining (NHEJ), which results in small indels close to the cut site. We reasoned that we could therefore estimate the double-strand break frequency by looking for the destruction of the restriction sites present in and around the &#x2212;3/&#x2212;4 position relative to the NGG, <italic>i.e.</italic>, the Cas9 cut site (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Note that only catastrophic events that result in sufficiently modified <italic>d10</italic> sites that could no longer be targeted by the Cas9/<italic>d10</italic>-sgRNA duplex would be detected in this way. This experiment therefore underestimates the double-strand break frequency since precise repair events using the sister chromatid would not be detected.</p>
<p>We selected four <italic>d10</italic>-entry strains on three different chromosomes (<italic>tag-68 I</italic>, <italic>egl-23 IV</italic>, <italic>twk-18 X</italic>, and <italic>unc-58 X</italic>). Each strain was injected with a DNA mixture containing (i) a Cas9 expression vector (pDD162), (ii) an sgRNA expression vector targeting <italic>dpy-10</italic> (pMD8), and (iii) a ssON to introduce the <italic>cn64</italic> mutation (AF-ZF-827) in <italic>dpy-10</italic> (<xref ref-type="bibr" rid="bib1">Arribere <italic>et al.</italic> 2014</xref>). Next, we singled F1 progeny showing a Dpy-10 phenotype, <italic>i.e.</italic>, Rol (<italic>cn64</italic>/+), Dpy (&#x2212;/&#x2212;), or DpyRol (<italic>cn64</italic>/&#x2212;) (<xref ref-type="bibr" rid="bib28">Levy <italic>et al.</italic> 1993</xref>; <xref ref-type="bibr" rid="bib1">Arribere <italic>et al.</italic> 2014</xref>). Finally, we tested all clones that segregated the Dpy-10 phenotype in their progeny and observed the loss of the <italic>Ban</italic>I site in 14&#x2013;26% of them (<xref ref-type="table" rid="t2">Table 2</xref>). Since <italic>Ban</italic>I is located 5&#x2032; to the cut site (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), we tested the remaining <italic>Ban</italic>I-positive clones (<italic>i.e.</italic>, lacking mutations in <italic>Ban</italic>I) with BsrBI and BssSI. This led us to identify additional events, likely affecting the bases closest to the &#x2212;3/&#x2212;4 cut site. In total, we found that between 33 and 52% of Dpy-10-marked F1 worms had lost at least one restriction site, which demonstrates that heterologous <italic>d10</italic> sites can be cut at high frequency and are present in Co-CRISPR-marked F1 progeny.</p>
<table-wrap id="t2" position="float">
<label>Table 2</label><caption><title>High CRISPR/Cas9 activity at transplanted <italic>d10</italic> site</title>
</caption>
<table frame="hsides">
<col width="27.49%"/>
<col width="13.89%"/>
<col width="19.34%"/>
<col width="18.45%"/>
<col width="20.83%"/>
<thead>
<tr>
<th valign="top" align="center" scope="col">Gene (WormBase ID)</th>
<th valign="top" align="center" scope="col">Number of Marked F1 Progeny</th>
<th valign="top" align="center" scope="col">Number of Clones Lacking <italic>Ban</italic>I Site (%)</th>
<th valign="top" align="center" scope="col">Number of Clones Lacking BsrBI [+BssSI] Site (%)</th>
<th valign="top" align="center" scope="col">Combined Number of Clones Lacking Restriction <!-- DBComment18 -->Sites<!-- Q18 --> (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row"><italic>tag-68 I</italic> (WBGene00006445)</td>
<td valign="top" align="center">45</td>
<td valign="top" align="center">11 (24%)</td>
<td valign="top" align="center">10 (22)</td>
<td valign="top" align="center">21 (47)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row"><italic>egl-23 IV</italic> (WBGene00001190)</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">7 (16%)</td>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row"><italic>twk-18 X</italic> (WBGene00006672)</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center">5 (14%)</td>
<td valign="top" align="center">4 [+3] (19)</td>
<td valign="top" align="center">12 (33)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row"><italic>unc-58 X</italic> (WBGene00006792)</td>
<td valign="top" align="center">42</td>
<td valign="top" align="center">11 (26%)</td>
<td valign="top" align="center">11 (26)</td>
<td valign="top" align="center">22 (52)</td>
</tr>
</tbody></table></table-wrap>
<p>Bioinformatic analysis predicts a single, low scoring, off-target site for the <italic>d10</italic> sgRNA, situated in the uncharacterized gene <italic>R12E2.15</italic> (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). We investigated potential off-target cutting of the <italic>d10</italic> sgRNA by analyzing the <italic>R12E2.15</italic> locus in 32 independent F1 worms that segregated the Dpy-10 phenotypes. None of these 32 lines showed scars around the potential off-target cut site of the <italic>d10</italic> sgRNA.</p>
<p>Given the high correlation between worms displaying Dpy-10 phenotypes and double-strand break events in the transplanted <italic>d10</italic>-site, and given the high selectivity of the <italic>d10</italic> sgRNA for the endogenous and transplanted sites, we chose to focus only on Dpy-10-marked Co-CRISPR individuals in our coconversion experiments.</p>
</sec>
<sec id="s13">
<title>Generation of multiple knock-in lines using a single d10-entry strain</title>
<p>As a proof of principle for our strategy, we targeted the <italic>twk-18</italic> locus. TWK-18 is one of 47 two-pore domain potassium channels in the <italic>C. elegans</italic> genome. Its expression pattern and localization in body wall muscle cells has been reported previously (<xref ref-type="bibr" rid="bib27">Kunkel <italic>et al.</italic> 2000</xref>). We decided to generate two N-terminal fusions (1) with the red fluorescent protein TagRFP-T (<xref ref-type="bibr" rid="bib35">Shaner <italic>et al.</italic> 2008</xref>) and (2) with the blue fluorescent protein TagBFP (<xref ref-type="bibr" rid="bib4">Chai <italic>et al.</italic> 2012</xref>). As a repair template, we constructed two vectors with left and right homology regions of 2073 and 1993 bp (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We injected each repair template separately into the <italic>twk-18 d10</italic>-entry strain (JIP1143) with (i) a Cas9 expression vector (pDD162), (ii) the sgRNA expression vector targeting <italic>dpy-10</italic> (pMD8), (iii) the ssON to introduce the <italic>cn64</italic> mutation in <italic>dpy-10</italic> (AF-ZF-827), and (iv) the fluorescent reporter pCFJ90 as a co-injection marker to identify transgenic animals based on mCherry fluorescence in the pharynx (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). We selected 77 (TagBFP) and 98 (TagRFP-T) Dpy-10-marked F1 progeny. Finally, we used PCR screening to identify five and six clones respectively, which had integrated the TagRFP-T and TagBFP sequences in the <italic>twk-18</italic> locus, corresponding to a recombination frequency of 6% of Dpy-10-marked F1 progeny (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
<fig id="fig2" position="float" fig-type="figure"><label>Figure 2</label><caption><p>Generation of multiple knock-in lines using a single <italic>d10</italic>-entry strain. (A) A single <italic>d10</italic>-entry strain is used to engineer N-terminal TagBFP, TagRFP-T, and wrmScarlet fusions in the <italic>twk-18</italic> locus. Correspondence of homology regions between the plasmid repair template and <italic>twk-18</italic> genomic locus is indicated in gray. RT, repair template. (B) Two to 3 days following injection of a <italic>d10</italic>-entry strain with a CRISPR/Cas9 mix, F1 progeny with Dpy-10 phenotypes (Rol or Dpy) can be easily recovered, and further screened in the F2 generation to identify the desired genome edits by PCR or phenotype.</p></caption><graphic xlink:href="ggg.040824fig2"></graphic></fig>
<table-wrap id="t3" position="float">
<label>Table 3</label><caption><title>Summary of genome editing experiments</title>
</caption>
<table frame="hsides">
<col width="25.57%"/>
<col width="20.55%"/>
<col width="17.86%"/>
<col width="19.56%"/>
<col width="16.46%"/>
<thead>
<tr>
<th valign="top" align="center" scope="col">Gene (WormBase ID)</th>
<th valign="top" align="center" scope="col">Inserted Sequence</th>
<th valign="top" align="center" scope="col">Proportion of P0 with Dpy-10 Progeny</th>
<th valign="top" align="center" scope="col">Proportion of Dpy-10-Marked F1 Progeny with Edits</th>
<th valign="top" align="center" scope="col">Percentage Edits per Dpy-10-Marked F1 Progeny (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row"><italic>sup-9 II</italic> (WBGene00006318)</td>
<td valign="top" align="center">TagRFP-T</td>
<td valign="top" align="center">11/42</td>
<td valign="top" align="center">4/142</td>
<td valign="top" align="center">3</td>
</tr>
<tr>
<td valign="top" align="left" scope="row"><italic>twk-40 III</italic> (WBGene00006691)</td>
<td valign="top" align="center">TagRFP-T::ZF1</td>
<td valign="top" align="center">16/35</td>
<td valign="top" align="center">3/45</td>
<td valign="top" align="center">7</td>
</tr>
<tr>
<td rowspan="6" valign="top" align="left" scope="row"><italic>egl-23 IV</italic> (WBGene00001190)</td>
<td valign="top" align="center">TagRFP-T</td>
<td valign="top" align="center">12/60</td>
<td valign="top" align="center">5/79</td>
<td valign="top" align="center">6</td>
</tr>
<tr>
<td valign="top" colspan="1" align="center" scope="row">SL2::TagRFP-T</td>
<td valign="top" align="center">9/63</td>
<td valign="top" align="center">3/37</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" colspan="1" align="center" scope="row">TagBFP</td>
<td valign="top" align="center">10/24</td>
<td valign="top" align="center">5/27</td>
<td valign="top" align="center">19</td>
</tr>
<tr>
<td valign="top" colspan="1" align="center" scope="row">TagBFP2</td>
<td valign="top" align="center">10/33</td>
<td valign="top" align="center">7/68</td>
<td valign="top" align="center">10</td>
</tr>
<tr>
<td valign="top" colspan="1" align="center" scope="row">wrmScarlet</td>
<td valign="top" align="center">19/35</td>
<td valign="top" align="center">14/190</td>
<td valign="top" align="center">7</td>
</tr>
<tr>
<td valign="top" colspan="1" align="center" scope="row">Myc-Myc</td>
<td valign="top" align="center">8/30</td>
<td valign="top" align="center">9/67</td>
<td valign="top" align="center">14</td>
</tr>
<tr>
<td rowspan="3" valign="top" align="left" scope="row"><italic>twk-18 X</italic> (WBGene00006672)</td>
<td valign="top" align="center">TagRFP-T</td>
<td valign="top" align="center">5/27</td>
<td valign="top" align="center">5/77</td>
<td valign="top" align="center">6</td>
</tr>
<tr>
<td valign="top" colspan="1" align="center" scope="row">TagBFP</td>
<td valign="top" align="center">4/20</td>
<td valign="top" align="center">6/98</td>
<td valign="top" align="center">6</td>
</tr>
<tr>
<td valign="top" colspan="1" align="center" scope="row">wrmScarlet</td>
<td valign="top" align="center">11/29</td>
<td valign="top" align="center">6/123</td>
<td valign="top" align="center">5</td>
</tr>
</tbody></table></table-wrap>
<p>When we prepared these knock-in lines for observation by confocal fluorescence microscopy, we noted that TWK-18-TagBFP had a very reproducible subcellular distribution at the exterior surface of body wall muscle cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The highly repetitive grid-like pattern was very different from the one reported previously since it appeared to show a strong green fluorescent protein signal in the endoplasmic reticulum (<xref ref-type="bibr" rid="bib27">Kunkel <italic>et al.</italic> 2000</xref>). This intracellular localization was not consistent with the electrophysiological effect of TWK-18 gain-of-function mutants, in which TWK-18 most likely exerts its hyper-polarizing role at the plasma membrane. We believe these differences probably resulted from a strong overexpression of TWK-18 in this study compared to our knock-in strain, highlighting the importance of physiological expression levels when observing the distribution of cell surface-targeted channels and receptors (<xref ref-type="bibr" rid="bib18">Gendrel <italic>et al.</italic> 2009</xref>). When comparing the TagRFP-T and TagBFP knock-in strains, we noticed not only a marked difference in brightness but also in the apparent resolution (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The overall pattern of TagRFP-T was similar to TagBFP but the longer emission wavelength of TagRFP-T (emission maximum, 584 nm) did not afford the same resolution as the much shorter emission wavelength of TagBFP (emission maximum, 457 nm). This is in part explained by the fact that resolution is proportional to the emission wavelength, making TagBFP an interesting alternative to increase imaging resolution without changing imaging hardware.</p>
<fig id="fig3" position="float" fig-type="figure"><label>Figure 3</label><caption><p>Comparison of TagBFP, TagRFP-T, and wrmScarlet using reliable editing of the <italic>twk-18</italic> locus. (A) wrmScarlet::TWK-18 is visibly brighter than TagRFP-T::TWK-18. Side-by-side comparison of two young adult hermaphrodites. wrmScarlet-associated fluorescence is visible by eye in freely moving worms on NGM plates, while TagRFP-T is not detectable by eye in this context. (B) The two-pore domain potassium channel TWK-18 decorates the plasma membrane of body wall muscle cells. Representative images of head muscle cells labeled with N-terminal fusions of TWK-18 to TagBFP, TagRFP-T, and wrmScarlet. Head is left. Bar, 10 &#x00B5;m. (C) Quantification of fluorescence intensity shows an eightfold increase in fluorescence between TagRFP-T and wrmScarlet. Mean &#x00B1; SD. <!-- DBComment17 -->Stud<!-- Q17 -->ent&#x2019;s <italic>t</italic>-test, &#x002A;<italic>P</italic> &#x003C; 0.0001.</p></caption><graphic xlink:href="ggg.040824fig3"></graphic></fig>
<p>Next, we targeted three additional loci on different chromosomes (<italic>sup-9 II</italic>, <italic>twk-40 III</italic>, and <italic>egl-23 IV</italic>) and generated seven different edits with a variety of insert types (TagRFP-T, TagRFP-T::ZF1, SL2::TagRFP-T, and TagBFP) (<xref ref-type="table" rid="t3">Table 3</xref> and Table S2 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). We found that we could reliably edit these different loci. Indeed, edit frequencies in Dpy-10-marked F1 worms ranged from 3 to 19% (average 8%). Taken together, these experiments demonstrate that it is possible to take advantage of the high CRISPR activity of the <italic>d10</italic> sgRNA to robustly engineer the genome of <italic>C. elegans</italic>. This strategy significantly reduces hands-on work by focusing only on the animals that most likely carry genome edits. It generates scarless edits since it does not require the introduction of mutations in endogenous protospacer sequences.</p>
</sec>
<sec id="s14">
<title>wrmScarlet, a brighter red fluorescent protein</title>
<p>The development of improved blue (TagBFP; <xref ref-type="bibr" rid="bib4">Chai <italic>et al.</italic> 2012</xref>), cyan (mTurquoise2; <xref ref-type="bibr" rid="bib20">Goedhart <italic>et al.</italic> 2012</xref>), green (mNeonGreen; <xref ref-type="bibr" rid="bib36">Shaner <italic>et al.</italic> 2013</xref>), and red fluorescent proteins (TagRFP-T; <xref ref-type="bibr" rid="bib35">Shaner <italic>et al.</italic> 2008</xref>) has greatly increased our capacity to detect proteins expressed at physiological levels. However, the properties of these new fluorophores are generally characterized in bacteria or cell culture systems, and are not always retained in <italic>C. elegans</italic> cells or in specific subcellular compartments (<xref ref-type="bibr" rid="bib21">Heppert <italic>et al.</italic> 2016</xref>).</p>
<p>In an effort to improve the detection of fusion proteins <italic>in vivo</italic>, we have investigated the behavior of the recently described red fluorescent protein mScarlet (<xref ref-type="bibr" rid="bib2">Bindels <italic>et al.</italic> 2017</xref>). mScarlet has currently the highest reported brightness, quantum yield, and fluorescence lifetime of any red fluorescent protein. We synthetized a <italic>C. elegans</italic> codon-optimized cDNA (<xref ref-type="bibr" rid="bib32">Redemann <italic>et al.</italic> 2011</xref>) of mScarlet, which we named wrmScarlet (Figure S3 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). We combined this cDNA with homology arms flanking the <italic>d10</italic> site in <italic>twk-18</italic> to generate a <italic>wrmScarlet</italic>::<italic>twk-18</italic> repair plasmid (pSEM87, <xref ref-type="fig" rid="fig2">Figure 2A</xref>, and Figure S3 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). Following the same strategy as before, we injected 29 P0 worms (<italic>twk-18 d10</italic>-entry strain, JIP1440) with an injection mix containing (i) pDD162 (Cas9), (ii) the ssON to introduce the <italic>cn64</italic> mutation in <italic>dpy-10</italic> (AF-ZF-827), (iii) the sgRNA expression vector targeting <italic>dpy-10</italic> (pMD8), and (iv) <italic>wrmScarlet</italic>::<italic>twk-18</italic> repair plasmid (pSEM87). Out of 29 injected P0 worms, 11 produced Dpy-10 F1 progeny. In total, we analyzed 123 Dpy-10-marked F1 worms that segregated Dpy-10 progeny and found six clones incorporating the wrmScarlet sequence (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
<p>While undetectable by eye, specific fluorescence can be observed on NGM plates in TagRFP-T::twk-18 worms with a macroscope (Nikon AZ100) coupled to a CMOS camera (Flash 4, Hamamatsu Photonics). Using the same macroscope, acquisition parameters and filter sets, wrmScarlet-TWK-18 was significantly brighter than the TagRFP-T fusion, so much so that it became visible to the naked eye (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We next compared the subcellular distribution and brightness of these two translational fusions using spinning-disk confocal imaging. Both protein fusions had grossly identical distribution patterns (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). However, the wrmScarlet fusion was &#x223C;8 times brighter than the TagRFT-T fusion in this assay (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In fact, the distribution of the wrmScarlet::TWK-18 fusion protein appeared more uniform than TagR<!-- Q14 -->FP-T::TWK-18, possibly due to the increased fluorescent signal, which compensated for the reduced resolution when compared to TagBFP (<xref ref-type="fig" rid="fig3">Figure 3B</xref>)<!-- DBComment14 -->. These properties make wrmScarlet a very convincing replacement for TagRFP-T and should greatly facilitate the detection of protein fusions expressed at low, physiological expression levels.</p>
</sec>
<sec id="s15">
<title>Generation of an epitope-tagged knock-in using a long single-strand oligonucleotide</title>
<p>For short edits, single-strand DNA oligonucleotides can be very efficient repair templates (<xref ref-type="bibr" rid="bib40">Zhao <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib1">Arribere <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib24">Katic <italic>et al.</italic> 2015</xref>). We tested if a large ssON could be used as a repair template to integrate two repeats of the myc-tag sequence into the <italic>egl-23</italic> locus (Figure S2 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). We synthetized a 182-nucleotide-long ssDNA fragment containing part of the last exon of <italic>egl-23</italic> to restore the full-length C-terminal sequence, followed by 75 nt encoding two myc<!-- Q15 --> tag sequences, and the original stop codon and 3&#x2032; UTR region of the <italic>egl-23</italic> gene (Table S3 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>)<!-- DBComment15 -->. In theory, each strand could serve as a template for recombination, but we selected the strand complementary to the sgRNA following the observations of <xref ref-type="bibr" rid="bib24">Katic <italic>et al.</italic> (2015</xref>). We injected 30 P0 worms (JIP1150) with a DNA mixture containing (i) a Cas9 expression vector (pDD162), (ii) the expression vector for the <italic>d10</italic> sgRNA (pMD8), (iii) the ssON that introduces the <italic>cn64</italic> mutation in <italic>dpy-10</italic> (AF-ZF-827), (iv) ssON containing the 2xMyc tag sequence (oSEM158), and (v) pCFJ90 as a co-injection marker to identify transgenic animals based on mCherry fluorescence in the pharynx. We selected 67 Dpy-10-marked F1 progeny and among these, nine carried the 2xMyc tag. This 14% edit frequency was comparable, yet slightly higher than the average efficiency of longer inserts using double-strand DNA repair templates (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
<p>The high edit efficiency observed in this experiment shows that our strategy is very effective to tag proteins of interest for immunohistochemical or protein biochemistry experiments. Generating this epitope-tagged strain required &#x003C;2 wk, with no additional cloning steps and could be repeated easily to integrate a variety of epitope tags, opening the way for different downstream applications.</p>
</sec>
<sec id="s16">
<title>Generation of a large, targeted deletion using a d10-entry strain</title>
<p>One starting point for many CRISPR experiments is the desire to engineer loss-of-function mutations in a gene of interest. Previously, researchers relied on random mutagenesis with chemical mutagens or ionizing radiation followed by fastidious screening and extensive backcrossing to wild-type strains to eliminate background mutations (<xref ref-type="bibr" rid="bib3">Boulin and Hobert 2012</xref>). CRISPR/Cas9 engineering offers the possibility to generate gene deletions with minimal background mutations. A simple approach relies on the repair of double-strand breaks by NHEJ pathways (<xref ref-type="bibr" rid="bib14">Friedland <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib5">Chen <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib23">Katic and Gro&#x00DF;hans 2013</xref>; <xref ref-type="bibr" rid="bib37">Waaijers <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib7">Dickinson and Goldstein 2016</xref>). One, two, or more sgRNAs are injected together and phenotypic or PCR screening strategies are used to retrieve deletion mutants by PCR amplification. However, the exact breakpoints of these deletions are not controllable in this scheme and there is always the potential for undesired edits due to off-target effects for each sgRNA.</p>
<p><italic>d10</italic>-entry strains can also serve as a starting point to generate precisely defined gene deletions. As a proof of principle, we targeted the <italic>egl-23</italic> locus. <italic>egl-23</italic> is a large locus comprising 12 exons, and removal of the entire <italic>egl-23a</italic> splice isoform required an 8-kb deletion (Figure S2 in <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1/FileS1.pdf">File S1</ext-link>). Our goal was to replace the complete <italic>egl-23</italic>a locus by a transgene expressing the red fluorescent protein mCherry in the pharynx which could be used as a genetic balancer and knock-out mutant of <italic>egl-23</italic>. We therefore constructed a repair template composed of two homology regions of 2 kb, which flanked the transcriptional reporter unit (<italic>Pmyo-2</italic>::<italic>mCherry</italic>::<italic>unc-54 3&#x2032;UTR</italic>). This construct was then injected into the appropriate <italic>egl-23 d10</italic>-entry strain (JIP1150) along with (i) a Cas9 expression vector (pDD162), (ii) the expression vector for the <italic>d10</italic> sgRNA (pMD8), and (iii) the ssON that introduces the <italic>cn64</italic> mutation in <italic>dpy-10</italic> (AF-ZF-827). Out of 40 Dpy-10 progeny, we identified one knock-out line (JIP1253). We validated that the genome edit was accurate by Sanger sequencing. We further verified that the possible off-target site of the <italic>d10</italic> sgRNA was unaffected (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). While this particular trial was less efficient than smaller insertions, it confirmed that <italic>d10</italic>-entry strains can be used to generate large deletion and gene replacements, in addition to being ideally suited for the insertion of kilobase-sized inserts or epitope tags.</p>
</sec>
</sec>
<sec id="s17" sec-type="discussion">
<title>Discussion</title>
<p>The major conceptual innovation of our strategy is to render genes highly susceptible to CRISPR/Cas9 engineering by transplanting the <italic>d10</italic> sequence. As we have described above, highly effective sgRNAs matching the GGNGG motif are underrepresented in the genome, and are therefore rarely found in close proximity to the region of interest. While editing frequency is highly variable between sgRNAs at different loci or even within the same locus, we found that editing using our <italic>d10</italic> strategy was robust at different loci, with edit frequencies averaging 8%, <italic>i.e.</italic>, 1 in 12 F1 progeny. In addition, editing was also robust at a single locus. This is particularly valuable and time-saving when multiple edits need to be generated in the same locus, as is usually the case when a gene is being characterized in depth. For example, we took advantage of this high editing frequency to rapidly generate multiple chromatic variants in the <italic>twk-18</italic> locus. This allowed us for the first time to precisely compare the resolution and fluorescence intensity of TagBFP, TagRFP-T, and the recently published mScarlet. Based on the highly stereotypical distribution pattern of TWK-18 at the muscle surface, we could show that (1) TagBFP fusions provided the best apparent resolution, (2) a codon-optimized wrmScarlet was &#x223C;8 times brighter than TagRFP-T, and (3) the increased signal of wrmScarlet partly compensated for the lesser resolution of red <italic>vs.</italic> blue fluorescent proteins.</p>
<p>One unique feature of our strategy is that edits can be designed so that all original genomic sequences are perfectly preserved. Indeed, by using the transplanted <italic>d10</italic> sgRNA instead of sgRNAs from the targeted locus, no mutations need to be introduced to avoid continued CRISPR/Cas9 activity once the edit is performed. This facilitates and accelerates experimental design, because only one repair template is designed instead of specific repair constructs for each endogenous sgRNA that would be considered for an edit.</p>
<p>Another benefit of our strategy is that we could retrieve multiple independent lines from the same injected animal by cloning animals in the F1 generation, which is not possible in strategies that rely on the screening of mixed populations of F2 progeny, <italic>e.g.</italic>, with antibiotic selection strategies. Therefore, since we could focus on relatively few F1 clones, multiple methods could be used to detect the desired genome edit such as direct observation, phenotypic screening, or PCR detection. Limiting the number of animals that need to be analyzed could also mitigate PCR detection issues (see <italic>PCR screening</italic>).</p>
<p>From a practical perspective, our strategy provides multiple layers of quality control. Based on the easily recognizable Dpy-10 Co-CRISPR phenotype, we could directly monitor the success of injections and assess the general efficiency of the experiment over time and between experimenters. We could determine if an experiment would likely be successful within 3 d postinjection by monitoring the number of marked F1 progeny. Finally, all steps of our protocol are only limited by the generation time of <italic>C. elegans</italic>, making it particularly time-efficient.</p>
<p>Obtaining the <italic>d10</italic>-entry strain is the major bottleneck of our strategy. This step, like every CRISPR/Cas9 experiment, relies (1) on the ability to find an endogenous sgRNA that cuts efficiently and (2) on the rate of homology directed repair at the cut site, which could be influenced by the local genomic context or specific sequence features of the homology arms. During this study, we were unable to recover <italic>d10</italic> insertions in some of our target loci despite testing multiple sgRNAs. For some genes, we eventually succeeded by using double-stranded DNA repair templates with long homology arms instead of single-strand oligonucleotides.</p>
<p>Another practical concern appears when targeting loci that are closely linked to <italic>unc-58</italic> (to build <italic>d10</italic>-entry strains) <italic>or dpy-10</italic> (to engineer <italic>d10</italic> loci), which are situated at the center of chromosome II and X, respectively. Since we select F1 progeny based on mutation of <italic>dpy-10</italic> or <italic>unc-58</italic>, it is likely that genome edits will be linked to these marker mutations. In that case, one should consider the wild-type siblings in the progeny of an injected P0 individual that produced a significant fraction of marked progeny.</p>
<p>So far, we have tested this strategy only with the <italic>d10</italic> sequence, but in principle, any highly effective sgRNA that targets a gene producing a dominant Co-CRISPR phenotype could be used. Conceptually, our strategy could also be extended to other genetic model organisms. In particular, a Co-CRISPR strategy based on the <italic>white</italic> locus has been recently published, and could be a starting point to adapt this strategy to engineer the <italic>Drosophil</italic>a genome (<xref ref-type="bibr" rid="bib17">Ge <italic>et al.</italic> 2016</xref>).</p>
</sec>
<sec id="s18">
<title></title>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank J.-L. Bessereau, I. Katic, and members of the Bessereau team for helpful discussion, M. Jospin for comments on the manuscript, and M. D&#x2019;Alessandro for constructing pMD8. pCFJ90 was a gift of C. Fr&#x00F8;kj&#x00E6;r-Jensen. We thank Wormbase, which is supported by National Institutes of Health grant U41 HG002223. This work was supported by a research grant from Fondation Fyssen (T.B.) and an European Research Council Starting Grant (Project <italic>Kelegans</italic>) (T.B.). This work is dedicated to the memory of Christian Boulin.</p>
</ack>
<fn-group><fn id="fn1"><p>Supplemental material is available online at <ext-link ext-link-type="uri" xlink:href="http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1">www.g3journal.org/lookup/suppl/doi:10.1534/g3.117.040824/-/DC1</ext-link>.</p></fn>
<fn id="fn2"><p><italic>Communicating editor: B. J. Andrews</italic></p></fn>
</fn-group>
<fn-group>
<title>AUTHOR QUERIES</title>
<fn id="Q1" fn-type="other"><p>Any alternations between capitalization and/or italics in genetic nomenclature have been retained per the original manuscript. Please confirm that all genetic nomenclature has been formatted properly throughout.</p></fn>
<fn id="Q2" fn-type="other"><p>Please verify corresponding author address.</p></fn>
<fn id="Q3" fn-type="other"><p>Please check all figure legends carefully to confirm that any and all labels, designators, directionals, colors, etc. are represented accurately in comparison with the figure images.</p></fn>
<fn id="Q4" fn-type="other"><p>Please note that the Supplemental Material links in your article will be live when it is published online.</p></fn>
<fn id="Q5" fn-type="other"><p>Please confirm or update any and all URLs in your article.</p></fn>
<fn id="Q6" fn-type="other"><p>Please check use of italics throughout your article, including all taxonomic and genetic nomenclature. Note that headings are set all Roman or all italics based on journal style and should not be changed. Uppercase Greek letters should remain roman per journal style even when appearing in a term where the overall style is italic (e.g., a gene name such as <italic>kap108</italic>&#x0394;).</p></fn>
<fn id="Q7" fn-type="other"><p>Check carefully for correct use of boldface, italics, operators, qualifiers, spacing, superscripts, and subscripts. Journal style includes Greek letters set roman (not italic), math variables italic, and variable modifiers roman type.) In inline and display equations, uppercase Greeks are roman and lowercase Greeks are italic. However, if an uppercase Greek is italicized in text as a math variable, it should be italicized in any corresponding display equations for consistency.</p></fn>
<fn id="Q8" fn-type="other"><p>Please check the WormBase links throughout. A list of entities linked in this article is available at <ext-link ext-link-type="uri" xlink:href="http://textpresso-dev.caltech.edu/gsa/worm/entity_link_tables/040824.html">http://textpresso-dev.caltech.edu/gsa/worm/entity_link_tables/040824.html.</ext-link></p></fn>
<fn id="Q9" fn-type="other"><p>Please specify an article section heading in place of &#x201C;below&#x201D; in sentence ending &#x201C;(see below and Supplementary Methods in File S1).&#x201D;</p></fn>
<fn id="Q10" fn-type="other"><p>Please confirm NGM is spelled out correctly as nematode growth media in the sentence beginning &#x201C;Freely moving worms were observed on NGM plates using an AZ100 macroscope&#x2026;&#x201D;.</p></fn>
<fn id="Q11" fn-type="other"><p>Please confirm CSU and EMCCD are spelled out correctly in the sentence beginning &#x201C;Confocal imaging was performed using an inverted confocal microscope&#x2026;&#x201D;.</p></fn>
<fn id="Q12" fn-type="other"><p>A sentence has been added to the <italic>Data availability</italic> section. Please confirm this is correct.</p></fn>
<fn id="Q13" fn-type="other"><p>Please confirm edits to the sentence beginning &#x201C;Our strategy starts with the insertion of the <italic>d10</italic> sequence (<italic>i.e.</italic>, <italic>dpy-10</italic> protospacer + PAM) into&#x2026;&#x201D;.</p></fn>
<fn id="Q14" fn-type="other"><p>Should it be &#x201C;TagRFP-T::TWK-18&#x201D; or &#x201C;TagRFP-T::twk-18&#x201D; (as used elsewhere) in the sentence beginning: &#x201C;In fact, the distribution of the wrmScarlet::TWK-18 fusion protein appeared more uniform than TagRFP-T::TWK-18, possibly due&#x2026;&#x201D;? See also Figure 3 legend.</p></fn>
<fn id="Q15" fn-type="other"><p>Should it be myc-tag as elsewhere in the following text &#x201C;&#x2026;followed by 75 nt encoding two myc tag sequences, and the&#x2026;&#x201D;?</p></fn>
<fn id="Q16" fn-type="other"><p>Lowercase letters a, b, c, and d were not added to part A of Figure 1, as the part descriptions did not seem to correlate with the first, second, third, and fourth parts of the figure. Please check legend, in-text mentions, and the artwork and correct as necessary. If necessary, provide updated artwork.</p></fn>
<fn id="Q17" fn-type="other"><p>Please check edit to Figure 3 legend: &#x201C;Student&#x2019;s <italic>t</italic>-test, &#x002A;<italic>P</italic> &#x003C; 0.0001&#x201D;.</p></fn>
<fn id="Q18" fn-type="other"><p>Should there be a footnote explaining why the last two columns are empty for <italic>egl-23 IV</italic> (WBGene00001190)?</p></fn></fn-group>
<ref-list>
<title>Literature Cited</title>
<ref id="bib1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arribere</surname><given-names>J. A.</given-names></name><name><surname>Bell</surname><given-names>R. T.</given-names></name><name><surname>Fu</surname><given-names>B. X. H.</given-names></name><name><surname>Artiles</surname><given-names>K. L.</given-names></name><name><surname>Hartman</surname><given-names>P. S.</given-names></name><etal/></person-group>, <year>2014</year>&#x2003;<article-title>Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in <italic>Caenorhabditis elegans</italic>.</article-title> <source>Genetics</source> <volume>198</volume>: <fpage>837</fpage>&#x2013;<lpage>846</lpage>.</citation></ref>
<ref id="bib2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bindels</surname><given-names>D. S.</given-names></name><name><surname>Haarbosch</surname><given-names>L.</given-names></name><name><surname>van Weeren</surname><given-names>L.</given-names></name><name><surname>Postma</surname><given-names>M.</given-names></name><name><surname>Wiese</surname><given-names>K. E.</given-names></name><etal/></person-group>, <year>2017</year>&#x2003;<article-title>mScarlet: a bright monomeric red fluorescent protein for cellular imaging.</article-title> <source>Nat. Methods</source> <volume>14</volume>: <fpage>53</fpage>&#x2013;<lpage>56</lpage>.</citation></ref>
<ref id="bib3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boulin</surname><given-names>T.</given-names></name><name><surname>Hobert</surname><given-names>O.</given-names></name></person-group>, <year>2012</year>&#x2003;<article-title>From genes to function: the <italic>C. elegans</italic> genetic toolbox.</article-title> <source>WIREs Dev Biol</source> <volume>1</volume>: <fpage>114</fpage>&#x2013;<lpage>137</lpage>.</citation></ref>
<ref id="bib4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><etal/></person-group>, <year>2012</year>&#x2003;<article-title>Live imaging of cellular dynamics during Caenorhabditis elegans postembryonic development.</article-title> <source>Nat. Protoc.</source> <volume>7</volume>: <fpage>2090</fpage>&#x2013;<lpage>2102</lpage>.</citation></ref>
<ref id="bib5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Fenk</surname><given-names>L. A.</given-names></name><name><surname>De Bono</surname><given-names>M.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>Efficient genome editing in <italic>Caenorhabditis elegans</italic> by CRISPR-targeted homologous recombination.</article-title> <source>Nucleic Acids Res.</source> <volume>41</volume>: <fpage>e193</fpage>.</citation></ref>
<ref id="bib6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>S. W.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Carroll</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>J.-S.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>Heritable gene knockout in <italic>Caenorhabditis elegans</italic> by direct injection of Cas9-sgRNA ribonucleoproteins.</article-title> <source>Genetics</source> <volume>195</volume>: <fpage>1177</fpage>&#x2013;<lpage>1180</lpage>.</citation></ref>
<ref id="bib7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>D. J.</given-names></name><name><surname>Goldstein</surname><given-names>B.</given-names></name></person-group>, <year>2016</year>&#x2003;<article-title>CRISPR-based methods for <italic>Caenorhabditis elegans</italic> genome engineering.</article-title> <source>Genetics</source> <volume>202</volume>: <fpage>885</fpage>&#x2013;<lpage>901</lpage>.</citation></ref>
<ref id="bib8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>D. J.</given-names></name><name><surname>Ward</surname><given-names>J. D.</given-names></name><name><surname>Reiner</surname><given-names>D. J.</given-names></name><name><surname>Goldstein</surname><given-names>B.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>Engineering the <italic>Caenorhabditis elegans</italic> genome using Cas9-triggered homologous recombination.</article-title> <source>Nat. Methods</source> <volume>10</volume>: <fpage>1028</fpage>&#x2013;<lpage>1034</lpage>.</citation></ref>
<ref id="bib9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>D. J.</given-names></name><name><surname>Pani</surname><given-names>A. M.</given-names></name><name><surname>Heppert</surname><given-names>J. K.</given-names></name><name><surname>Higgins</surname><given-names>C. D.</given-names></name><name><surname>Goldstein</surname><given-names>B.</given-names></name></person-group>, <year>2015</year>&#x2003;<article-title>Streamlined genome engineering with a self-excising drug selection cassette.</article-title> <source>Genetics</source> <volume>200</volume>: <fpage>1035</fpage>&#x2013;<lpage>1049</lpage>.</citation></ref>
<ref id="bib10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doench</surname><given-names>J. G.</given-names></name><name><surname>Hartenian</surname><given-names>E.</given-names></name><name><surname>Graham</surname><given-names>D. B.</given-names></name><name><surname>Tothova</surname><given-names>Z.</given-names></name><name><surname>Hegde</surname><given-names>M.</given-names></name><etal/></person-group>, <year>2014</year>&#x2003;<article-title>Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.</article-title> <source>Nat. Biotechnol.</source> <volume>32</volume>: <fpage>1262</fpage>&#x2013;<lpage>1267</lpage>.</citation></ref>
<ref id="bib11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doench</surname><given-names>J. G.</given-names></name><name><surname>Fusi</surname><given-names>N.</given-names></name><name><surname>Sullender</surname><given-names>M.</given-names></name><name><surname>Hegde</surname><given-names>M.</given-names></name><name><surname>Vaimberg</surname><given-names>E. W.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.</article-title> <source>Nat. Biotechnol.</source> <volume>34</volume>: <fpage>184</fpage>&#x2013;<lpage>191</lpage>.</citation></ref>
<ref id="bib12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doudna</surname><given-names>J. A.</given-names></name><name><surname>Charpentier</surname><given-names>E.</given-names></name></person-group>, <year>2014</year>&#x2003;<article-title> The new frontier of genome engineering with CRISPR-Cas9.</article-title> <source>Science</source> <volume>346</volume>: <fpage>1258096</fpage>.</citation></ref>
<ref id="bib13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farboud</surname><given-names>B.</given-names></name><name><surname>Meyer</surname><given-names>B. J.</given-names></name></person-group>, <year>2015</year>&#x2003;<article-title>Dramatic enhancement of genome editing by CRISPR/Cas9 through improved guide RNA design.</article-title> <source>Genetics</source> <volume>199</volume>: <fpage>959</fpage>&#x2013;<lpage>971</lpage>.</citation></ref>
<ref id="bib14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedland</surname><given-names>A. E.</given-names></name><name><surname>Tzur</surname><given-names>Y. B.</given-names></name><name><surname>Esvelt</surname><given-names>K. M.</given-names></name><name><surname>Colai&#x00E1;covo</surname><given-names>M. P.</given-names></name><name><surname>Church</surname><given-names>G. M.</given-names></name><etal/></person-group>, <year>2013</year>&#x2003;<article-title>Heritable genome editing in <italic>C. elegans</italic> via a CRISPR-Cas9 system.</article-title> <source>Nat. Methods</source> <volume>10</volume>: <fpage>741</fpage>&#x2013;<lpage>743</lpage>.</citation></ref>
<ref id="bib15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x00F8;kj&#x00E6;r-Jensen</surname><given-names>C.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>Exciting prospects for precise engineering of <italic>Caenorhabditis elegans</italic> genomes with CRISPR/Cas9.</article-title> <source>Genetics</source> <volume>195</volume>: <fpage>635</fpage>&#x2013;<lpage>642</lpage>.</citation></ref>
<ref id="bib16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x00F8;kj&#x00E6;r-Jensen</surname><given-names>C.</given-names></name><name><surname>Davis</surname><given-names>M. W.</given-names></name><name><surname>Taylor</surname><given-names>J.</given-names></name><name><surname>Harris</surname><given-names>T. W.</given-names></name><name><surname>Moerman</surname><given-names>D. G.</given-names></name><etal/></person-group>, <year>2010</year>&#x2003;<article-title>Targeted gene deletions in <italic>C. elegans</italic> using transposon excision.</article-title> <source>Nat. Methods</source> <volume>7</volume>: <fpage>451</fpage>&#x2013;<lpage>453</lpage>.</citation></ref>
<ref id="bib17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>D. T.</given-names></name><name><surname>Tipping</surname><given-names>C.</given-names></name><name><surname>Brodsky</surname><given-names>M. H.</given-names></name><name><surname>Zamore</surname><given-names>P. D.</given-names></name></person-group>, <year>2016</year>&#x2003;<article-title>Rapid screening for CRISPR-directed editing of the <italic>Drosophila</italic> genome using <italic>white</italic> coconversion.</article-title> <source>G3</source> <volume>6</volume>: <fpage>3197</fpage>&#x2013;<lpage>3206</lpage>.</citation></ref>
<ref id="bib18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gendrel</surname><given-names>M.</given-names></name><name><surname>Rapti</surname><given-names>G.</given-names></name><name><surname>Richmond</surname><given-names>J. E.</given-names></name><name><surname>Bessereau</surname><given-names>J.-L.</given-names></name></person-group>, <year>2009</year>&#x2003;<article-title>A secreted complement-control-related protein ensures acetylcholine receptor clustering.</article-title> <source>Nature</source> <volume>461</volume>: <fpage>992</fpage>&#x2013;<lpage>996</lpage>.</citation></ref>
<ref id="bib19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>D. G.</given-names></name></person-group>, <year>2011</year>&#x2003;<article-title>Enzymatic assembly of overlapping DNA fragments.</article-title> <source>Methods Enzymol.</source> <volume>498</volume>: <fpage>349</fpage>&#x2013;<lpage>361</lpage>.</citation></ref>
<ref id="bib20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goedhart</surname><given-names>J.</given-names></name><name><surname>Stetten von</surname><given-names>D.</given-names></name><name><surname>Noirclerc-Savoye</surname><given-names>M.</given-names></name><name><surname>Lelimousin</surname><given-names>M.</given-names></name><name><surname>Joosen</surname><given-names>L.</given-names></name><etal/></person-group>, <year>2012</year>&#x2003;<article-title>Structure-guided evolution of cyan fluorescent proteins towards a quantum yield of 93%.</article-title> <source>Nat. Commun.</source> <volume>3</volume>: <fpage>751</fpage>.</citation></ref>
<ref id="bib21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heppert</surname><given-names>J. K.</given-names></name><name><surname>Dickinson</surname><given-names>D. J.</given-names></name><name><surname>Pani</surname><given-names>A. M.</given-names></name><name><surname>Higgins</surname><given-names>C. D.</given-names></name><name><surname>Steward</surname><given-names>A.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>Comparative assessment of fluorescent proteins for in vivo imaging in an animal model system.</article-title> <source>Mol. Biol. Cell</source> <volume>27</volume>: <fpage>3385</fpage>&#x2013;<lpage>3394</lpage>.</citation></ref>
<ref id="bib22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>P. D.</given-names></name><name><surname>Scott</surname><given-names>D. A.</given-names></name><name><surname>Weinstein</surname><given-names>J. A.</given-names></name><name><surname>Ran</surname><given-names>F. A.</given-names></name><name><surname>Konermann</surname><given-names>S.</given-names></name><etal/></person-group>, <year>2013</year>&#x2003;<article-title>DNA targeting specificity of RNA-guided Cas9 nucleases.</article-title> <source>Nat. Biotechnol.</source> <volume>31</volume>: <fpage>827</fpage>&#x2013;<lpage>832</lpage>.</citation></ref>
<ref id="bib23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katic</surname><given-names>I.</given-names></name><name><surname>Gro&#x00DF;hans</surname><given-names>H.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>Targeted heritable mutation and gene conversion by Cas9-CRISPR in <italic>Caenorhabditis elegans</italic>.</article-title> <source>Genetics</source> <volume>195</volume>: <fpage>1173</fpage>&#x2013;<lpage>1176</lpage>.</citation></ref>
<ref id="bib24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katic</surname><given-names>I.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Ciosk</surname><given-names>R.</given-names></name></person-group>, <year>2015</year>&#x2003;<article-title>CRISPR/Cas9 genome editing in <italic>Caenorhabditis elegans</italic>: evaluation of templates for homology-mediated repair and knock-ins by homology-independent DNA repair.</article-title> <source>G3</source> <volume>5</volume>: <fpage>1649</fpage>&#x2013;<lpage>1656</lpage>.</citation></ref>
<ref id="bib25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>W. G.</given-names></name><name><surname>Fire</surname><given-names>A.</given-names></name></person-group>, <year>1998</year>&#x2003;<article-title>Chromatin silencing and the maintenance of a functional germline in Caenorhabditis elegans.</article-title> <source>Development</source> <volume>125</volume>: <fpage>2451</fpage>&#x2013;<lpage>2456</lpage>.</citation></ref>
<ref id="bib26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Ishidate</surname><given-names>T.</given-names></name><name><surname>Ghanta</surname><given-names>K. S.</given-names></name><name><surname>Seth</surname><given-names>M.</given-names></name><name><surname>Conte</surname><given-names>D.</given-names></name><etal/></person-group>, <year>2014</year>&#x2003;<article-title>A co-CRISPR strategy for efficient genome editing in <italic>Caenorhabditis elegans</italic>.</article-title> <source>Genetics</source> <volume>197</volume>: <fpage>1069</fpage>&#x2013;<lpage>1080</lpage>.</citation></ref>
<ref id="bib27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunkel</surname><given-names>M. T.</given-names></name><name><surname>Johnstone</surname><given-names>D. B.</given-names></name><name><surname>Thomas</surname><given-names>J. H.</given-names></name><name><surname>Salkoff</surname><given-names>L.</given-names></name></person-group>, <year>2000</year>&#x2003;<article-title>Mutants of a temperature-sensitive two-P domain potassium channel.</article-title> <source>J. Neurosci.</source> <volume>20</volume>: <fpage>7517</fpage>&#x2013;<lpage>7524</lpage>.</citation></ref>
<ref id="bib28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>A. D.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Kramer</surname><given-names>J. M.</given-names></name></person-group>, <year>1993</year>&#x2003;<article-title>Molecular and genetic analyses of the Caenorhabditis elegans dpy-2 and dpy-10 collagen genes: a variety of molecular alterations affect organismal morphology.</article-title> <source>Mol. Biol. Cell</source> <volume>4</volume>: <fpage>803</fpage>&#x2013;<lpage>817</lpage>.</citation></ref>
<ref id="bib29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>A. D.</given-names></name><name><surname>Kim</surname><given-names>H.-M.</given-names></name><name><surname>Colai&#x00E1;covo</surname><given-names>M. P.</given-names></name><name><surname>Calarco</surname><given-names>J. A.</given-names></name></person-group>, <year>2015</year>&#x2003;<article-title>Efficient genome editing in <italic>Caenorhabditis elegans</italic> with a toolkit of dual-marker selection cassettes.</article-title> <source>Genetics</source> <volume>201</volume>: <fpage>449</fpage>&#x2013;<lpage>458</lpage>.</citation></ref>
<ref id="bib30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paix</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Smith</surname><given-names>H. E.</given-names></name><name><surname>Lee</surname><given-names>C.-Y. S.</given-names></name><name><surname>Calidas</surname><given-names>D.</given-names></name><etal/></person-group>, <year>2014</year>&#x2003;<article-title>Scalable and versatile genome editing using linear DNAs with microhomology to Cas9 sites in <italic>Caenorhabditis elegans</italic>.</article-title> <source>Genetics</source> <volume>198</volume>: <fpage>1347</fpage>&#x2013;<lpage>1356</lpage>.</citation></ref>
<ref id="bib31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paix</surname><given-names>A.</given-names></name><name><surname>Folkmann</surname><given-names>A.</given-names></name><name><surname>Rasoloson</surname><given-names>D.</given-names></name><name><surname>Seydoux</surname><given-names>G.</given-names></name></person-group>, <year>2015</year>&#x2003;<article-title>High efficiency, homology-directed genome editing in <italic>Caenorhabditis elegans</italic> using CRISPR-Cas9 ribonucleoprotein complexes.</article-title> <source>Genetics</source> <volume>201</volume>: <fpage>47</fpage>&#x2013;<lpage>54</lpage>.</citation></ref>
<ref id="bib32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redemann</surname><given-names>S.</given-names></name><name><surname>Schloissnig</surname><given-names>S.</given-names></name><name><surname>Ernst</surname><given-names>S.</given-names></name><name><surname>Pozniakowsky</surname><given-names>A.</given-names></name><name><surname>Ayloo</surname><given-names>S.</given-names></name><etal/></person-group>, <year>2011</year>&#x2003;<article-title>Codon adaptation-based control of protein expression in <italic>C. elegans</italic>.</article-title> <source>Nat. Methods</source> <volume>8</volume>: <fpage>250</fpage>&#x2013;<lpage>252</lpage>.</citation></ref>
<ref id="bib33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>V.</given-names></name><name><surname>Bessereau</surname><given-names>J.-L.</given-names></name></person-group>, <year>2007</year>&#x2003;<article-title>Targeted engineering of the <italic>Caenorhabditis elegans</italic> genome following <italic>Mos1</italic>-triggered chromosomal breaks.</article-title> <source>EMBO J.</source> <volume>26</volume>: <fpage>170</fpage>&#x2013;<lpage>183</lpage>.</citation></ref>
<ref id="bib34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>M. L.</given-names></name><name><surname>Jorgensen</surname><given-names>E. M.</given-names></name></person-group>, <year>2016</year>&#x2003;<article-title>SapTrap, a toolkit for high-throughput CRISPR/Cas9 gene modification in <italic>Caenorhabditis elegans</italic>.</article-title> <source>Genetics</source> <volume>202</volume>: <fpage>1277</fpage>&#x2013;<lpage>1288</lpage>.</citation></ref>
<ref id="bib35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaner</surname><given-names>N. C.</given-names></name><name><surname>Lin</surname><given-names>M. Z.</given-names></name><name><surname>McKeown</surname><given-names>M. R.</given-names></name><name><surname>Steinbach</surname><given-names>P. A.</given-names></name><name><surname>Hazelwood</surname><given-names>K. L.</given-names></name><etal/></person-group>, <year>2008</year>&#x2003;<article-title>Improving the photostability of bright monomeric orange and red fluorescent proteins.</article-title> <source>Nat. Methods</source> <volume>5</volume>: <fpage>545</fpage>&#x2013;<lpage>551</lpage>.</citation></ref>
<ref id="bib36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaner</surname><given-names>N. C.</given-names></name><name><surname>Lambert</surname><given-names>G. G.</given-names></name><name><surname>Chammas</surname><given-names>A.</given-names></name><name><surname>Ni</surname><given-names>Y.</given-names></name><name><surname>Cranfill</surname><given-names>P. J.</given-names></name><etal/></person-group>, <year>2013</year>&#x2003;<article-title>A bright monomeric green fluorescent protein derived from <italic>Branchiostoma lanceolatum</italic>.</article-title> <source>Nat. Methods</source> <volume>10</volume>: <fpage>407</fpage>&#x2013;<lpage>409</lpage>.</citation></ref>
<ref id="bib37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waaijers</surname><given-names>S.</given-names></name><name><surname>Portegijs</surname><given-names>V.</given-names></name><name><surname>Kerver</surname><given-names>J.</given-names></name><name><surname>Lemmens</surname><given-names>B. B. L. G.</given-names></name><name><surname>Tijsterman</surname><given-names>M.</given-names></name><etal/></person-group>, <year>2013</year>&#x2003;<article-title>CRISPR/Cas9-targeted mutagenesis in <italic>Caenorhabditis elegans</italic>.</article-title> <source>Genetics</source> <volume>195</volume>: <fpage>1187</fpage>&#x2013;<lpage>1191</lpage>.</citation></ref>
<ref id="bib38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>J. D.</given-names></name></person-group>, <year>2015</year>&#x2003;<article-title>Rapid and precise engineering of the <italic>Caenorhabditis elegans</italic> genome with lethal mutation co-conversion and inactivation of NHEJ repair.</article-title> <source>Genetics</source> <volume>199</volume>: <fpage>363</fpage>&#x2013;<lpage>377</lpage>.</citation></ref>
<ref id="bib39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zetsche</surname><given-names>B.</given-names></name><name><surname>Gootenberg</surname><given-names>J. S.</given-names></name><name><surname>Abudayyeh</surname><given-names>O. O.</given-names></name><name><surname>Slaymaker</surname><given-names>I. M.</given-names></name><name><surname>Makarova</surname><given-names>K. S.</given-names></name><etal/></person-group>, <year>2015</year>&#x2003;<article-title>Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.</article-title> <source>Cell</source> <volume>163</volume>: <fpage>759</fpage>&#x2013;<lpage>771</lpage>.</citation></ref>
<ref id="bib40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Ke</surname><given-names>H.</given-names></name><name><surname>Yue</surname><given-names>Y.</given-names></name><name><surname>Xue</surname><given-names>D.</given-names></name></person-group>, <year>2014</year>&#x2003;<article-title>Oligonucleotide-based targeted gene editing in <italic>C. elegans</italic> via the CRISPR/Cas9 system.</article-title> <source>Nature Publishing Group</source> <volume>24</volume>: <fpage>247</fpage>&#x2013;<lpage>250</lpage>.</citation></ref>
</ref-list></back>
</article>
